1. Home
  2. VCEL vs APPN Comparison

VCEL vs APPN Comparison

Compare VCEL & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.89

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$22.65

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
APPN
Founded
1989
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
VCEL
APPN
Price
$35.89
$22.65
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$57.50
$37.80
AVG Volume (30 Days)
417.8K
1.2M
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
236.54
N/A
EPS
0.25
N/A
Revenue
$258,716,999.00
$690,755,000.00
Revenue This Year
$18.02
$17.93
Revenue Next Year
$18.52
$12.07
P/E Ratio
$145.81
N/A
Revenue Growth
14.05
15.96
52 Week Low
$29.24
$22.19
52 Week High
$58.77
$46.06

Technical Indicators

Market Signals
Indicator
VCEL
APPN
Relative Strength Index (RSI) 42.11 26.44
Support Level $33.30 $22.19
Resistance Level $36.56 $26.30
Average True Range (ATR) 1.56 1.48
MACD -0.27 -0.22
Stochastic Oscillator 28.50 7.56

Price Performance

Historical Comparison
VCEL
APPN

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: